Published in Clin Exp Immunol on September 01, 2003
Immune disorders in Hashimoto's thyroiditis: what do we know so far? J Immunol Res (2015) 0.91
Xenobiotic exposure and autoimmune hepatitis. Hepat Res Treat (2010) 0.80
Targeting apoptosis in autoimmune hepatitis. Dig Dis Sci (2014) 0.80
High Serum IgG4 Concentrations in Patients with Hashimoto's Thyroiditis. Int J Endocrinol (2015) 0.75
Is Graves' disease a primary immunodeficiency? New immunological perspectives on an endocrine disease. BMC Med (2017) 0.75
Apoptosis by death factor. Cell (1997) 14.42
Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest (1998) 13.05
Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell (1995) 5.64
Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science (1995) 4.80
Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity (1998) 3.03
Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell (1999) 2.74
Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science (1997) 2.56
The role of Fas in autoimmune diabetes. Cell (1997) 2.30
IL-15 and IL-2: a matter of life and death for T cells in vivo. Nat Med (2001) 2.29
An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome. Ann Intern Med (1999) 2.20
The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood (2001) 2.15
Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ (1999) 2.02
Neonatal beta-cell apoptosis: a trigger for autoimmune diabetes? Diabetes (2000) 1.92
Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis. Science (1997) 1.53
Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J Exp Med (1997) 1.51
Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. J Immunol (1997) 1.49
Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. J Immunol (1997) 1.41
Cell death: TRAIL and its receptors. Curr Biol (1997) 1.28
Defective T cell fas function in patients with multiple sclerosis. Neurology (2000) 1.24
Role of apoptosis in autoimmunity. Apoptosis (2000) 1.15
Functional Fas ligand expression in thyrocytes from patients with Graves' disease. J Clin Endocrinol Metab (1999) 1.11
Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation. Blood (1997) 1.10
Remnants of suicidal cells fostering systemic autoaggression. Apoptosis in the origin and maintenance of autoimmunity. Arthritis Rheum (2000) 1.03
Apoptosis in thyroid tissue from patients with Hashimoto's thyroiditis. Autoimmunity (1995) 0.97
Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer. Blood (2000) 0.96
Fas-FasL interactions: a common pathogenetic mechanism in organ-specific autoimmunity. Immunol Today (1998) 0.92
Defective function of Fas in patients with type 1 diabetes associated with other autoimmune diseases. Diabetes (2001) 0.91
Sonographic diagnosis and grading of Hashimoto's thyroiditis. J Endocrinol Invest (1991) 0.89
Fas/Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto's thyroiditis. J Clin Endocrinol Metab (1998) 0.86
Frequent mutations of Fas gene in thyroid lymphoma. Cancer Res (2001) 0.85
Role of apoptosis of thyrocytes in a rat model of goiter. A possible involvement of Fas system. Endocrinology (1998) 0.83
Serum concentration of soluble Fas in patients with autoimmune thyroid diseases. Thyroid (1998) 0.82
Apoptosis in human autoimmune diseases. Int Rev Immunol (1999) 0.81
Increased serum soluble Fas in patients with Graves' disease. Thyroid (1999) 0.81
Fas-Mediated apoptosis is inhibited by TSH and iodine in moderate concentrations in primary human thyrocytes in vitro. Horm Metab Res (1999) 0.79
CD4+ T cell-mediated cytotoxicity toward thyrocytes: the importance of Fas/Fas ligand interaction inducing apoptosis of thyrocytes and the inhibitory effect of thyroid-stimulating hormone. Lab Invest (2000) 0.78
Expression of bcl-2, Bax and Fas in oxyphil cells of Hashimoto thyroiditis. Virchows Arch (2000) 0.78
The role of Fas-mediated apoptosis in thyroid autoimmune disease. Autoimmunity (1999) 0.78
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A (2001) 24.34
European Hernia Society guidelines on the treatment of inguinal hernia in adult patients. Hernia (2009) 7.05
The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat Genet (1999) 6.23
Quenching of protein fluorescence by oxygen. Detection of structural fluctuations in proteins on the nanosecond time scale. Biochemistry (1973) 4.28
Fluorescent modification of adenosine-containing coenzymes. Biological activities and spectroscopic properties. Biochemistry (1972) 4.06
Dynamics of fluorescence polarization in macromolecules. Proc Natl Acad Sci U S A (1972) 3.79
Synthesis and spectral properties of a hydrophobic fluorescent probe: 6-propionyl-2-(dimethylamino)naphthalene. Biochemistry (1979) 3.75
Pressure stability of proteins. Annu Rev Phys Chem (1993) 3.31
Update with level 1 studies of the European Hernia Society guidelines on the treatment of inguinal hernia in adult patients. Hernia (2014) 3.20
Ligand binding and internal equilibria in proteins. Biochemistry (1972) 2.97
Search for a resonance decaying into WZ boson pairs in pp collisions. Phys Rev Lett (2010) 2.83
Resolution of the fluorescence excitation spectrum of indole into the 1La and 1Lb excitation bands. Photochem Photobiol (1977) 2.65
Dynamics and time-averaged chemical potential of proteins: importance in oligomer association. Proc Natl Acad Sci U S A (1982) 2.58
Energetics of ligand binding to proteins. Adv Protein Chem (1975) 2.51
Quenching of fluorescence by oxygen. A probe for structural fluctuations in macromolecules. Biochemistry (1973) 2.48
Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Hum Mol Genet (1997) 2.45
The effect of high pressure upon proteins and other biomolecules. Q Rev Biophys (1983) 2.42
Microviscosity and order in the hydrocarbon region of micelles and membranes determined with fluorescent probes. I. Synthetic micelles. Biochemistry (1971) 2.36
The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect Immun (1999) 2.35
Cooperative effects in binding by bovine serum albumin. I. The binding of 1-anilino-8-naphthalenesulfonate. Fluorimetric titrations. Biochemistry (1966) 2.32
Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. Clowes Memorial Lecture. Cancer Res (1983) 2.30
Synthesis and characterization of two fluorescent sulfhydryl reagents. Biochemistry (1973) 2.26
Pressure-induced reversible dissociation of enolase. Biochemistry (1981) 2.17
[Relationship between psoriasis and human growth hormone (author's transl)]. MMW Munch Med Wochenschr (1980) 2.13
Psoriasis and human growth hormone: aetiology and therapy. Arch Dermatol Res (1981) 2.12
Pressure dissociation and conformational drift of the beta dimer of tryptophan synthase. Biochemistry (1986) 2.12
Zn(II) dependence of the Aeromonas hydrophila AE036 metallo-beta-lactamase activity and stability. Biochemistry (1997) 2.11
Mutations in ribosomal protein S19 gene and diamond blackfan anemia: wide variations in phenotypic expression. Blood (1999) 2.07
Enzymology of cancer cells (second of two parts). N Engl J Med (1977) 2.00
[Correlation of growth hormone and aetiology of psoriasis]. Arch Dermatol Res (1981) 1.97
Microviscosity and order in the hydrocarbon region of phospholipid and phospholipid-cholesterol dispersions determined with fluorescent probes. Biochemistry (1973) 1.94
Feedback inhibition of key glycolytic enzymes in liver: action of free fatty acids. Science (1966) 1.85
A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am J Hum Genet (1998) 1.78
Oxygen quenching of pyrenebutyric acid fluorescence in water. A dynamic probe of the microenvironment. Biochemistry (1970) 1.75
Conformational drift of dissociated lactate dehydrogenases. Biochemistry (1986) 1.74
Estimation of the polarity of the protein interior by optical spectroscopy. Nature (1986) 1.71
Treatment of psoriasis with bromocriptin. Arch Dermatol Res (1981) 1.70
Synchronous behavior pattern of key glycolytic enzymes: glucokinase, phosphofructokinase, and pyruvate kinase. Adv Enzyme Regul (1966) 1.69
Conformational drift and cryoinactivation of lactate dehydrogenase. Biochemistry (1986) 1.64
[Enzymatic mechanisms in psoriasis vulgaris]. Arch Klin Exp Dermatol (1966) 1.63
[Theories of nursing professionals about the elderly]. Pflege (1997) 1.63
Plasma membrane hydroxyethyl radical adducts cause antibody-dependent cytotoxicity in rat hepatocytes exposed to alcohol. Gastroenterology (1997) 1.63
IMP dehydrogenase, an enzyme linked with proliferation and malignancy. Nature (1975) 1.62
Enzymology of cancer cells (first of two parts). N Engl J Med (1977) 1.61
Minimal incidence of neonatal/infancy onset diabetes in Italy is 1:90,000 live births. Acta Diabetol (2011) 1.59
Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J Immunol (1998) 1.59
Alterations of the MEN1 gene in sporadic parathyroid tumors. J Clin Endocrinol Metab (1998) 1.58
An outbreak of Streptococcus pneumoniae serotype 1 in a closed community in southern Israel. Clin Infect Dis (2000) 1.57
Detection of hyperreactive T cells in multiple myeloma by multivalent cross-linking of the CD3/TCR complex. Blood (1991) 1.56
Regulation of gluconeogenesis and glycolysis: studies of mechanisms controlling enzyme activity. Adv Enzyme Regul (1967) 1.54
Hereditary factors in sleepwalking and night terrors. Br J Psychiatry (1980) 1.54
Measurement of the forward-backward charge asymmetry in top-quark pair production. Phys Rev Lett (2008) 1.53
Neuropsychiatric side effects after the use of mefloquine. Am J Trop Med Hyg (1991) 1.53
Enzymic imbalance in serine metabolism in human colon carcinoma and rat sarcoma. Br J Cancer (1988) 1.52
Down syndrome: MR quantification of brain structures and comparison with normal control subjects. AJNR Am J Neuroradiol (1992) 1.50
Fluorescence polarization of the complexes of 1-anilino-8-naphthalenesulfonate with bovine serum albumin. Evidence for preferential orientation of the ligand. Biochemistry (1969) 1.50
Phenomenological description of the association of protein subunits subjected to conformational drift. Effects of dilution and of hydrostatic pressure. Biochemistry (1986) 1.49
In vitro and in vivo effect of glucocorticoids on IgE and IgG subclass secretion. Clin Exp Allergy (1994) 1.47
Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism. J Clin Endocrinol Metab (1998) 1.46
Hyperbilirubinemia, glucose-6-phosphate-dehydrogenase deficiency and Gilbert's syndrome. Eur J Pediatr (1999) 1.45
Increased insulin-like growth factor (IGF)-II and IGF/IGF-binding protein ratio in prepubertal constitutionally tall children. J Clin Endocrinol Metab (2002) 1.45
Circulating ghrelin levels in the newborn are positively associated with gestational age. Clin Endocrinol (Oxf) (2004) 1.44
Cloning and characterization of a novel human gene related to vascular endothelial growth factor. Genome Res (1996) 1.43
Two distinct cDNAs for human IMP dehydrogenase. J Biol Chem (1990) 1.43
Radiation dose to technicians per nuclear medicine procedure: comparison between technetium-99m, gallium-67, and iodine-131 radiotracers and fluorine-18 fluorodeoxyglucose. Eur J Nucl Med (1997) 1.42
Two sibs with Malpuech syndrome. Am J Med Genet (1999) 1.42
The modulation of serine metabolism in hepatoma 3924A during different phases of cellular proliferation in culture. Biochem J (1987) 1.40
Osteopontin induces soluble urokinase-type plasminogen activator receptor production and release. Minerva Anestesiol (2014) 1.40
The diagnostic accuracy of self-report for determining S4-5 sensory and motor function in people with spinal cord injury. Spinal Cord (2011) 1.39
Post-surgical metabolic imbalance in adolescents with renal hypophosphatemic rickets. J Pediatr Endocrinol Metab (2000) 1.39
Pyrimidine 5'-nucleotidase acquired deficiency in beta-thalassemia: involvement of enzyme-SH groups in the inactivation process. Acta Haematol (1989) 1.39
Effect of gluten-free diet on bone mineral content in growing patients with celiac disease. Am J Clin Nutr (1993) 1.37
Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. Arthritis Rheum (2005) 1.37
The effect of magnesium on some physical properties of yeast enolase. J Biol Chem (1966) 1.36
Asthma self-management programmes in a population of Italian children: a multicentric study. Italian Study Group on Asthma Self-Management Programmes. Eur Respir J (1997) 1.35
Enzymic imbalance in serine metabolism in rat hepatomas. Biochem J (1986) 1.34
Photo-induced benzyl substitution of flavins by phenylacetate: a possible model for flavoprotein catalysis. Nature (1967) 1.33
Analysis of the cytogenetic stability of the human embryonal kidney cell line 293 by cytogenetic and STR profiling approaches. Cytogenet Genome Res (2004) 1.33
Dimer formation from 1-amino-8-naphthalenesulfonate catalyzed by bovine serum albumin. A new fluorescent molecule with exceptional binding properties. Biochemistry (1969) 1.32
Nanosecond segmental mobilities of tryptophan residues in proteins observed by lifetime-resolved fluorescence anisotropies. Biophys J (1980) 1.32
Treatment of psoriasis with somatostatin. Arch Dermatol Res (1982) 1.31
Role of CD38 in HIV-1 infection: an epiphenomenon of T-cell activation or an active player in virus/host interactions? AIDS (2000) 1.30
Characterization and comparison of poly(adenosine dephosphoribose) synthesis and DNA synthesis in nucleotide-permeable cells. Biochim Biophys Acta (1978) 1.30
X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene. Nat Genet (1995) 1.29
Fluorescence depolarization of rabbit gamma globulin conjugates. J Mol Biol (1967) 1.28
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients. J Neurooncol (2008) 1.27
Distribution of metals in human lung: analysis by particle induced x-ray emission. Arch Environ Health (1982) 1.26
Limbic encephalitis in children and adolescents. Arch Dis Child (2010) 1.26
Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemia. Br J Haematol (2000) 1.26
Defective T cell fas function in patients with multiple sclerosis. Neurology (2000) 1.24
Imbalance in ornithine metabolism in hepatomas of different growth rates as expressed in formation of putrescine, spermidine, and spermine. Cancer Res (1972) 1.23
Mutations in the ribosomal protein gene RPL10 suggest a novel modulating disease mechanism for autism. Mol Psychiatry (2006) 1.23
Volume scanning in the evaluation of fetal malformations: a new dimension in prenatal diagnosis. Ultrasound Obstet Gynecol (1995) 1.22
A differential polarized phase fluorometric study of the effects of high hydrostatic pressure upon the fluidity of cellular membranes. Biochemistry (1983) 1.16
Growth and sexual maturation in thalassemia major. J Pediatr (1985) 1.16
Establishment and characterization of the follicular thyroid carcinoma cell line ML-1. J Mol Med (Berl) (2000) 1.15